Case Report
Complete renal and haematological remission in a case of mantle cell lymphoma associated paraneoplastic focal segmental glomerulosclerosis with ibrutinib: a case report and review of literature
Annals of Lymphoma
2023;
7:
2
(30 March 2023)
Original Article
Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
Annals of Lymphoma
2023;
7:
1
(28 February 2023)
Review Article
State of the art in the diagnosis, biology and treatment of primary mediastinal B-cell lymphoma: a review
Annals of Lymphoma
2022;
6:
13
(30 December 2022)
Review Article
Older patients with mantle cell lymphoma: initial and subsequent therapies—a narrative review
Annals of Lymphoma
2022;
6:
12
(30 December 2022)
Review Article
Clinical geriatric assessment in older patients with lymphoma: a narrative review
Annals of Lymphoma
2022;
6:
11
(30 September 2022)
Review Article
Age is just a number: managing relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in older patients
Annals of Lymphoma
2022;
6:
10
(30 September 2022)
Review Article
Initial treatment of elderly population with aggressive lymphoma: a narrative review of current evidence and future directions
Annals of Lymphoma
2022;
6:
9
(30 September 2022)
Review Article
Transplant and chimeric antigen receptor T-cell therapies in elderly patients with lymphoma, a narrative review
Annals of Lymphoma
2022;
6:
8
(30 September 2022)
Review Article
Diffuse large B-cell lymphoma among the elderly: a narrative review of current knowledge and future perspectives
Annals of Lymphoma
2022;
6:
6
(30 June 2022)
Review Article
Adoptive cellular immunotherapy for Epstein-Barr virus-associated lymphoproliferative disease
Annals of Lymphoma
2022;
6:
5
(30 June 2022)
Editorial
The diversity challenges in follicular lymphoma
Annals of Lymphoma
2022;
6:
4
(30 June 2022)
Case Report
The gamma delta lymphomas: an Australian multi-centre case series
Annals of Lymphoma
2022;
6:
3
(30 March 2022)
Case Report
Complete response of relapsed adult T-cell lymphoma leukemia to a Bcl-2 inhibitor: a case report
Annals of Lymphoma
2022;
6:
2
(30 March 2022)
Review Article
Primary diffuse large B-cell lymphoma of the central nervous system: molecular and biological features of neoplastic cells
Annals of Lymphoma
2022;
6:
1
(30 March 2022)
Case Report
Daratumumab as first line therapy in primary effusion lymphoma: a case report
Annals of Lymphoma
2021;
5:
33
(30 December 2021)
Review Article
Minimal residual disease in follicular lymphoma
Annals of Lymphoma
2021;
5:
32
(30 December 2021)
Review Article
From pathobiology to targeted treatment in Epstein Barr virus related T cell and Natural Killer cell lymphoproliferative diseases
Annals of Lymphoma
2021;
5:
31
(30 December 2021)
Review Article
The contribution of ebv to the pathogenesis of classical hodgkin lymphoma
Annals of Lymphoma
2021;
5:
30
(30 September 2021)
Review Article
Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management
Annals of Lymphoma
2021;
5:
29
(30 September 2021)
Review Article
Tumor microenvironment of follicular lymphoma
Annals of Lymphoma
2021;
5:
28
(30 September 2021)
Review Article
Primary central nervous system lymphoma: advances in MRI and PET imaging
Annals of Lymphoma
2021;
5:
27
(30 September 2021)
Review Article
HIV-associated lymphoma—advances in clinical management
Annals of Lymphoma
2021;
5:
26
(30 September 2021)
Review Article
Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review
Annals of Lymphoma
2021;
5:
25
(30 September 2021)